- Home
- MREO vs CMP Comparison
MREO vs CMP Comparison
Compare MREO & CMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- CMP
- Stock Information
- Founded
- MREO 2015
- CMP 1993
- Country
- MREO United Kingdom
- CMP United States
- Employees
- MREO N/A
- CMP N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- CMP Other Metals and Minerals
- Sector
- MREO Health Care
- CMP Basic Materials
- Exchange
- MREO Nasdaq
- CMP Nasdaq
- Market Cap
- MREO 482.5M
- CMP 493.5M
- IPO Year
- MREO N/A
- CMP 2003
- Fundamental
- Price
- MREO $2.50
- CMP $10.02
- Analyst Decision
- MREO Strong Buy
- CMP Buy
- Analyst Count
- MREO 6
- CMP 3
- Target Price
- MREO $7.83
- CMP $18.33
- AVG Volume (30 Days)
- MREO 1.5M
- CMP 608.1K
- Earning Date
- MREO 03-26-2025
- CMP 05-06-2025
- Dividend Yield
- MREO N/A
- CMP N/A
- EPS Growth
- MREO N/A
- CMP N/A
- EPS
- MREO N/A
- CMP N/A
- Revenue
- MREO $1,000,000.00
- CMP $1,082,900,000.00
- Revenue This Year
- MREO N/A
- CMP $4.71
- Revenue Next Year
- MREO N/A
- CMP $7.26
- P/E Ratio
- MREO N/A
- CMP N/A
- Revenue Growth
- MREO N/A
- CMP N/A
- 52 Week Low
- MREO $2.25
- CMP $7.51
- 52 Week High
- MREO $5.02
- CMP $20.24
- Technical
- Relative Strength Index (RSI)
- MREO 38.26
- CMP 36.91
- Support Level
- MREO $2.39
- CMP $9.90
- Resistance Level
- MREO $2.59
- CMP $10.46
- Average True Range (ATR)
- MREO 0.17
- CMP 0.56
- MACD
- MREO 0.02
- CMP -0.04
- Stochastic Oscillator
- MREO 39.87
- CMP 15.43
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About CMP Compass Minerals Intl Inc
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.